Sanofi signals beyond the news: 45+ signals from 7 sources
The latest Sanofi signal on this page is from Sep 29, 2026 (Patents): "Sanofi Biotechnology was granted a patent for rheumatoid arthritis treatment compositions." The busiest sources: LinkedIn (15+), Website changes (14) and Patents (8).
PublicPharmaceutical Manufacturing10,000+ employeessanofi.comLinkedIn
- Signals
- 45+
- Sources
- 7
- Last 90 days
- 40
- Latest
- Sep 29, 2026
Other signals · latest 10
Latest Sanofi signals by source
45+ signals for Sanofi across 7 sources.
Patents · Patent grant
Sanofi Biotechnology was granted a patent for rheumatoid arthritis treatment compositions.
In September 2026 Sanofi Biotechnology patented combination therapy for treating rheumatoid arthritis and improving symptoms in clinical care.
- Patent title
- Compositions for the treatment of rheumatoid arthritis and methods of using same
- Grant date
- Sep 29, 2026
- Inventors
- Xiaohong Huang, Martine Jasson, Vanessa Marks, Allen Radin
Patents · Patent pace
Sanofi-Aventis Deutschland GMBH's patent output is slowing: 43 grants in the past year, 0 in the past 30 days.
Over the past year Sanofi-Aventis Deutschland GMBH received 43 US patent grants, concentrated in pumps / compressors and pumps; the recent pace (6 in 90 days) is slowing versus its trailing baseline.
- Grants, 12 months
- 43
- Grants, 90 days
- 6
- Grants, 30 days
- 0
- Pace
- Decelerating
Reddit · Customer feedback
A commenter criticizes Sanofi for using an outdated CTMS called IMPACT, having disorganized study managers, and being one of the worst sponsors they've worked with.
Post: "Sponsor/FSP Rankings"
- Subreddit
- r/clinicalresearch
- Upvotes
- 24
- Comments
- 46
- Sentiment
- Negative
Website changes · Marketing shift
Sanofi increased emphasis on its rare-disease and translational research pipeline, including bispecific therapeutics and dual-targeting strategies.
Added coverage of “Dual-targeting library designing novel bispecific therapeutics” and “Advancing the Next Generation of Immune-Mediated Disease Treatments.”
- Page
- /
Website changes · Market data
Sanofi published its Q2 2026 financial report and related press-release materials.
Added press release: “Sanofi’s half-year financial report for 2026.”
- Page
- /en/media-room/press-releases
Web traffic · Traffic snapshot
sanofi.com received 869K monthly visits with traffic from 5 countries.
Minimal AI traffic at 0.9% (~7,999 visits). Top: chatgpt.com (89%), perplexity.ai (6%), gemini.google.com (5%).
- Monthly visits
- 869,063
- Month over month
- +15.5%
- 3-month change
- +12.8%
- Global rank
- 62,811
LinkedIn
Marmerex USA announces EU approval for infant use of its meningococcal vaccine.
The European Commission has approved an indication extension in the European Union for our Meningococcal Group A, C, W and Y conjugate vaccine to include use in infants from as young as 6 weeks of age to help protect against invasive meningococcal disease. Read our press release: http://spkl.io/60427z52s
- Likes
- 1,183
- Comments
- 24
- Tags
- Pharmaceuticals, Product Launch, Medical Research, Compliance
- Initiatives
- extending infant age indication for meningococcal vaccine
Web traffic · Sustained decline
sanofi.com shows sustained decline with 3 consecutive months of decreases, down 16% overall to 753K.
Minimal AI traffic at 0.9% (~5,941 visits). Top: chatgpt.com (58%), perplexity.ai (28%), claude.ai (11%), gemini.google.com (0%).
- Monthly visits
- 752,675
- Month over month
- -2.3%
- 3-month change
- -15.7%
- Global rank
- 70,448
Conference talks
Emmanuel Frenehard (Chief Digital Officer, Sanofi) at Snowflake Summit 26.
- Conference
- Snowflake Summit 26
- Date
- Jun 1, 2026
- Location
- San Francisco, California, USA
- Topics
- enterprise data, generative AI, machine learning, data engineering
Employee growth · Marketing team growth
2,712 Marketing employees (3.0% of company), growing slowly (1% YoY).
The Marketing department currently has 2,712 employees out of 90,410 total (3.0%). The department is growing slowly (1% YoY), representing a change of approximately +27 employees.
- Department
- Marketing
- Department headcount
- 2,712
- Department growth, 1 year
- +1%
- Total headcount
- 90,410
Showing 10 of 45+ signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Sanofi with the Signal API
One POST /v1/companies/enrich call with sanofi.com returns Sanofi signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{
"domain": "sanofi.com",
"signal_types": ["reddit-company","podcast-company","glassdoor-company",
"product-reviews","linkedin-post-company","twitter-company-posts",
"youtube-company","website-intelligence","patents-company",
"federal-contract-award","conference-speaker","hackernews",
"producthunt-launch","seo-traffic"],
"limit": 20
}'Same industry
Other signals at related companies
Questions about Sanofi other signals
What signals does Autobound track for Sanofi besides news and filings?
What are people saying about Sanofi online?
Has Sanofi been granted patents recently?
Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.
Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.
Data as of .